Pranab Maiti

Title: Pranab Maiti: Innovator in TEAD Transcription Factor Inhibition

Introduction

Pranab Maiti is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of molecular biology, particularly in the development of small molecule inhibitors targeting TEAD transcription factors. His work is crucial in advancing therapeutic options for diseases associated with these transcription factors.

Latest Patents

Pranab Maiti holds a patent for "Small molecule inhibitors of TEAD transcription factors." This patent describes compounds that inhibit the activity of the TEAD transcription factor. These compounds are particularly useful in treating diseases related to TEAD activity, including cancer and other serious conditions. He has 1 patent to his name, showcasing his innovative approach to addressing critical health issues.

Career Highlights

Maiti is associated with The General Hospital Corporation, where he applies his expertise in molecular biology and pharmacology. His work at this institution has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his research.

Collaborations

Some of his notable coworkers include Chandrasekhar Abbineni and Krishna Chaitanya Talluri. Their collaborative efforts contribute to the advancement of research in the area of TEAD transcription factors and their inhibitors.

Conclusion

Pranab Maiti's innovative work in developing small molecule inhibitors of TEAD transcription factors represents a significant advancement in the treatment of diseases like cancer. His contributions to the field highlight the importance of research and collaboration in driving medical innovation.